Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEXPAN-WOUND: Subcutaneous Dexpanthenol for Chronic Wounds
NCT07395674Not yet recruiting
- Start
- Dec 2026
- Primary completion
- Aug 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of dexpanthenol in Chronic wound, diabetic foot ulcer (DFU), venous leg ulcer (VLU) and 1 more (2 arms). Primary endpoint: Percentage Change in Wound Area at Day 26. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
dexpanthenol
03
Conditions
Chronic wounddiabetic foot ulcer (DFU)venous leg ulcer (VLU)arterial ulcer
Beyond the preview
Go deeper on NCT07395674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07395674.